Intersect ENT received CMS approval of a revised coding application for its Propel sinus implant, according to a Jan. 19 news release. Propel previously shared a billing code with Intersect ENT’s ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Steroid-eluting implants inserted during or after sinus surgery may benefit patients with chronic sinusitis with or without nasal polyps, including those who can't tolerate oral steroids, a consensus ...
Mani Zadeh, MD, an otolaryngologist at La Peer Health Systems who practices in Beverly Hills, is among the first in the United States to use the PROPEL device to perform sinus implants on an ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Medical device maker Medtronic said on Friday it would buy Intersect ENT Inc for $936.2 million in cash as it looks to bolster its offerings for ear, nose and throat procedures. The Dublin, ...
Acquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in ...
The Federal Trade Commission says Medtronic can move forward with a proposed acquisition so long as the company promptly divests a subsidiary that makes certain medical devices used in sinus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback